Ozone therapy ameliorates tubulointerstitial inflammation by regulating TLR4 in adenine-induced CKD rats
Authors:
Open Access
- 24 February 2016
- journal article
- research article
- Published by Taylor & Francis in Renal Failure
- Vol. 38 (5) , 822-830
Abstract
Tubulointerstitium inflammation is a common pathway aggravating chronic kidney disease (CKD) progression and the mechanism is partly associated with excessive activation of toll-like receptor 4 (TLR4) in tubulointerstitium. Ozone therapy is demonstrated to alleviate inflammation in some experiments. The aim of this study is to examine whether ozone therapy could ameliorate chronic tubulointerstitium inflammation by suppressing TLR4 in adenine-induced CKD rats. Sprague–Dawley rats were fed with 0.75% adenine-containing diet to induce CKD and tubulointerstitium inflammation injury. Ozone therapy (1.1 mg/kg) was simultaneously administrated by rectal insufflations (i.r.). After 4 weeks, serum and kidney samples were collected for detection. Renal function and systemic electrolyte were detected. Renal pathological changes were assessed by hematoxylin-eosin (H&E) staining and Masson trichrome (MT) staining. Immunohistochemistry, Western blot and Real-time PCR were applied to evaluate tubulointerstitium inflammation as well as the expression of TLR4 and phosphorylated nuclear factor kappa B P65 (p-NF-κB P65) in rats. The results showed ozone therapy improved serious renal insufficiency, systemic electrolyte disorder and tubulointerstitium morphology damages in adenine-induced CKD rats. In addition, ozone therapy suppressed excessive activation of TLR4 and p-NF-κB P65 in the tubulointerstitium of adenine-induced CKD rats, accompanied by the reduction of inflammation-related cytokines including monocyte chemoattractant protein-1 (MCP-1), tumor necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and interleukin-6 (IL-6). The protein expression of TLR4 was positively correlated with the protein expression levels of MCP-1 (r = 0.7863, p < 0.01) and TNF-α (r = 0.7547, p < 0.01) in CKD rats. These findings indicated ozone therapy could attenuate tubulointerstitium inflammation injury in adenine-induced CKD rats and the mechanism might associate with the mediation of TLR4.Keywords
This publication has 32 references indexed in Scilit:
- Parthenolide inhibits LPS-induced inflammatory cytokines through the toll-like receptor 4 signal pathway in THP-1 cellsActa Biochimica et Biophysica Sinica, 2015
- Toll-Like Receptor 4 in Inflammation and Angiogenesis: A Double-Edged SwordFrontiers in Immunology, 2014
- Reliable and effective oxygen-ozone therapy at a crossroads with ozonated saline infusion and ozone rectal insufflationJournal of Pharmacy and Pharmacology, 2012
- Tubulointerstitial injury and the progression of chronic kidney diseasePediatric Nephrology, 2011
- Renal TLR4 mRNA Expression Correlates with Inflammatory Marker MCP-1 and Profibrotic Molecule TGF-β1 in Patients with Chronic Kidney DiseaseNephron Clinical Practice, 2011
- Mechanisms of Action Involved in Ozone Therapy: Is healing induced via a mild oxidative stress?Medical Gas Research, 2011
- Toll-Like Receptors and Renal DiseaseNephron Experimental Nephrology, 2009
- The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney diseaseKidney International, 2006
- Strategies to Retard the Progression of Chronic Kidney DiseaseMedical Clinics of North America, 2005
- Signaling DangerJournal of the American Society of Nephrology, 2004